REPRESENTATIVE INVESTIGATION MATTERS

  • Represented a global healthcare company in SEC investigation of potential FCPA violations in connection with government tender in Iraq
  • Represented multinational pharmaceutical corporation in DOJ investigation of potential FCPA violations in connection with the government tender for vaccine in Russia
  • Investigated alleged improper payments and the use of unauthorized subcontractors by a US aircraft parts manufacturing company in South-East Asia
  • Investigated alleged kickbacks by American multinational computer technology corporation to government distributors in Russia
  • Advised Indonesian branch of a US pharmaceutical company on a fraud investigation triggered by employees who misappropriated the client's discount cards in Indonesia
  • Investigated a multinational technology company's operations in India in relation to government bribery allegations
  • Investigated alleged kickbacks by a Russian media vendor of a multinational pharmaceutical company
  • Investigated allegations of discount abuse by a government distributor of a multinational pharmaceutical company in Romania
  • Investigated allegations of embezzlement by event management vendor of a multinational pharmaceutical company in Czech RepubliC
  • Investigated allegations of misappropriation of marketing budget by the country manager of a global healthcare company in Mongolia
  • Investigated alleged misuse of product samples and forgery of internal corporate documents by employees of a multinational pharmaceutical company in Philippines
  • Conducted FCPA investigation for a premier biopharmaceutical company of alleged improper payments to senior government official in Ministry of Health of Russia in exchange for increased purchases of client's products

REPRESENTATIVE REGULATORY COMPLIANCE MATTERS

  • Performed global anti-corruption risk and compliance audits and assessments for a multinational pharmaceutical company in Kazakhstan
  • Provided FCPA/anti-corruption training to employees, officers, and audit committee members of a multinational pharmaceutical company in Kazakhstan 
  • Counseled on FCPA/anti-money laundering due diligence protocols applicable to a U.S. insurance company establishing a bank in Moscow
  • Investigated allegations of potential off-label promotion of products by consultants of pharmaceutical company in Philippines and South Korea.

REPRESENTATIVE CORPORATE MATTERS

  • Conducted corporate/anti-corruption due diligence for a multinational pharmaceutical company on various supply and distribution arrangements with counterparties in Russia and Kazakhstan
  • Performed due diligence in M&A transactions, equity offerings and project finance, including construction of LNG plant for Kazakh oil and gas exploration group

REPRESENTATIVE SANCTIONS MATTERS

  • Performed due diligence of supply arrangements with distributors and direct customers of US welding manufacturer in Russia to assess trade compliance rules as well as compliance with OFAC/sanctions legislation